nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—Taste metallic—Metformin—polycystic ovary syndrome	0.028	0.0978	CcSEcCtD
Paricalcitol—CYP24A1—endometrium—polycystic ovary syndrome	0.0166	0.128	CbGeAlD
Paricalcitol—CYP3A4—urine—polycystic ovary syndrome	0.0129	0.0993	CbGeAlD
Paricalcitol—CYP24A1—vagina—polycystic ovary syndrome	0.0124	0.0956	CbGeAlD
Paricalcitol—CYP24A1—endocrine gland—polycystic ovary syndrome	0.0116	0.0895	CbGeAlD
Paricalcitol—UGT1A4—endocrine gland—polycystic ovary syndrome	0.0116	0.0895	CbGeAlD
Paricalcitol—Fungal infection—Metformin—polycystic ovary syndrome	0.0115	0.0403	CcSEcCtD
Paricalcitol—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.011	0.0384	CcSEcCtD
Paricalcitol—VDR—adrenal cortex—polycystic ovary syndrome	0.0102	0.0787	CbGeAlD
Paricalcitol—Chest discomfort—Metformin—polycystic ovary syndrome	0.0101	0.0351	CcSEcCtD
Paricalcitol—VDR—uterus—polycystic ovary syndrome	0.00843	0.0648	CbGeAlD
Paricalcitol—VDR—pituitary gland—polycystic ovary syndrome	0.00828	0.0636	CbGeAlD
Paricalcitol—VDR—adipose tissue—polycystic ovary syndrome	0.00824	0.0633	CbGeAlD
Paricalcitol—Lightheadedness—Metformin—polycystic ovary syndrome	0.00797	0.0278	CcSEcCtD
Paricalcitol—Cholecalciferol—CYP11A1—polycystic ovary syndrome	0.00747	0.455	CrCbGaD
Paricalcitol—VDR—adrenal gland—polycystic ovary syndrome	0.0074	0.0568	CbGeAlD
Paricalcitol—VDR—female gonad—polycystic ovary syndrome	0.0069	0.053	CbGeAlD
Paricalcitol—VDR—vagina—polycystic ovary syndrome	0.00685	0.0527	CbGeAlD
Paricalcitol—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00662	0.0231	CcSEcCtD
Paricalcitol—VDR—endocrine gland—polycystic ovary syndrome	0.00641	0.0493	CbGeAlD
Paricalcitol—Ergocalciferol—AR—polycystic ovary syndrome	0.00609	0.371	CrCbGaD
Paricalcitol—Dehydration—Metformin—polycystic ovary syndrome	0.00601	0.021	CcSEcCtD
Paricalcitol—Breast disorder—Metformin—polycystic ovary syndrome	0.00584	0.0204	CcSEcCtD
Paricalcitol—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00578	0.0202	CcSEcCtD
Paricalcitol—Influenza—Metformin—polycystic ovary syndrome	0.00559	0.0195	CcSEcCtD
Paricalcitol—Pancreatitis—Metformin—polycystic ovary syndrome	0.00548	0.0191	CcSEcCtD
Paricalcitol—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00535	0.0187	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00519	0.0181	CcSEcCtD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00502	0.00885	CbGpPWpGaD
Paricalcitol—Infestation NOS—Metformin—polycystic ovary syndrome	0.00498	0.0174	CcSEcCtD
Paricalcitol—Infestation—Metformin—polycystic ovary syndrome	0.00498	0.0174	CcSEcCtD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00495	0.00874	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—LIF—polycystic ovary syndrome	0.00486	0.00857	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.00474	0.00836	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—NCOR1—polycystic ovary syndrome	0.00468	0.00825	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—AR—polycystic ovary syndrome	0.00467	0.00823	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.00451	0.00795	CbGpPWpGaD
Paricalcitol—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00445	0.0155	CcSEcCtD
Paricalcitol—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0044	0.0154	CcSEcCtD
Paricalcitol—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00439	0.0153	CcSEcCtD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00438	0.00772	CbGpPWpGaD
Paricalcitol—Eye disorder—Metformin—polycystic ovary syndrome	0.00418	0.0146	CcSEcCtD
Paricalcitol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00415	0.0145	CcSEcCtD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00407	0.00718	CbGpPWpGaD
Paricalcitol—Angiopathy—Metformin—polycystic ovary syndrome	0.00406	0.0142	CcSEcCtD
Paricalcitol—UGT1A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00404	0.00713	CbGpPWpGaD
Paricalcitol—Immune system disorder—Metformin—polycystic ovary syndrome	0.00404	0.0141	CcSEcCtD
Paricalcitol—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00403	0.0141	CcSEcCtD
Paricalcitol—Chills—Metformin—polycystic ovary syndrome	0.00401	0.014	CcSEcCtD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00397	0.00701	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—polycystic ovary syndrome	0.00396	0.00698	CbGpPWpGaD
Paricalcitol—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.00392	0.00691	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00392	0.00691	CbGpPWpGaD
Paricalcitol—Malnutrition—Metformin—polycystic ovary syndrome	0.00389	0.0136	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.00385	0.00679	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00381	0.00672	CbGpPWpGaD
Paricalcitol—Dysgeusia—Metformin—polycystic ovary syndrome	0.00381	0.0133	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.00377	0.00666	CbGpPWpGaD
Paricalcitol—Muscle spasms—Metformin—polycystic ovary syndrome	0.00374	0.0131	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.00369	0.0065	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00361	0.0126	CcSEcCtD
Paricalcitol—UGT1A4—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.00359	0.00633	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.00358	0.00632	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.00358	0.00632	CbGpPWpGaD
Paricalcitol—Malaise—Metformin—polycystic ovary syndrome	0.00351	0.0123	CcSEcCtD
Paricalcitol—Syncope—Metformin—polycystic ovary syndrome	0.00349	0.0122	CcSEcCtD
Paricalcitol—Palpitations—Metformin—polycystic ovary syndrome	0.00344	0.012	CcSEcCtD
Paricalcitol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00342	0.0119	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NRG1—polycystic ovary syndrome	0.00338	0.00596	CbGpPWpGaD
Paricalcitol—Hypertension—Metformin—polycystic ovary syndrome	0.00336	0.0117	CcSEcCtD
Paricalcitol—Myalgia—Metformin—polycystic ovary syndrome	0.00331	0.0116	CcSEcCtD
Paricalcitol—Chest pain—Metformin—polycystic ovary syndrome	0.00331	0.0116	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00329	0.0115	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—BCL2—polycystic ovary syndrome	0.00328	0.00578	CbGpPWpGaD
Paricalcitol—Discomfort—Metformin—polycystic ovary syndrome	0.00327	0.0114	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.00325	0.00574	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00322	0.00568	CbGpPWpGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.0032	0.00565	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.0032	0.00564	CbGpPWpGaD
Paricalcitol—Oedema—Metformin—polycystic ovary syndrome	0.00318	0.0111	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.00317	0.00558	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00316	0.00557	CbGpPWpGaD
Paricalcitol—Infection—Metformin—polycystic ovary syndrome	0.00316	0.011	CcSEcCtD
Paricalcitol—Shock—Metformin—polycystic ovary syndrome	0.00312	0.0109	CcSEcCtD
Paricalcitol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00311	0.0109	CcSEcCtD
Paricalcitol—Skin disorder—Metformin—polycystic ovary syndrome	0.00309	0.0108	CcSEcCtD
Paricalcitol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00307	0.0107	CcSEcCtD
Paricalcitol—Anorexia—Metformin—polycystic ovary syndrome	0.00303	0.0106	CcSEcCtD
Paricalcitol—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.00302	0.00532	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—BAX—polycystic ovary syndrome	0.003	0.00529	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.00298	0.00526	CbGpPWpGaD
Paricalcitol—Hypotension—Metformin—polycystic ovary syndrome	0.00297	0.0104	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.00292	0.00516	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00289	0.0101	CcSEcCtD
Paricalcitol—Paraesthesia—Metformin—polycystic ovary syndrome	0.00285	0.00996	CcSEcCtD
Paricalcitol—Cholecalciferol—CYP1A1—polycystic ovary syndrome	0.00284	0.173	CrCbGaD
Paricalcitol—Dyspnoea—Metformin—polycystic ovary syndrome	0.00283	0.00989	CcSEcCtD
Paricalcitol—Somnolence—Metformin—polycystic ovary syndrome	0.00282	0.00986	CcSEcCtD
Paricalcitol—CYP24A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00281	0.00496	CbGpPWpGaD
Paricalcitol—Dyspepsia—Metformin—polycystic ovary syndrome	0.0028	0.00976	CcSEcCtD
Paricalcitol—Decreased appetite—Metformin—polycystic ovary syndrome	0.00276	0.00964	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00274	0.00958	CcSEcCtD
Paricalcitol—Fatigue—Metformin—polycystic ovary syndrome	0.00274	0.00956	CcSEcCtD
Paricalcitol—Constipation—Metformin—polycystic ovary syndrome	0.00272	0.00948	CcSEcCtD
Paricalcitol—CYP24A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00263	0.00463	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00262	0.00914	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0026	0.00907	CcSEcCtD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.0026	0.00458	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00259	0.00457	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.00255	0.00449	CbGpPWpGaD
Paricalcitol—Urticaria—Metformin—polycystic ovary syndrome	0.00252	0.00881	CcSEcCtD
Paricalcitol—Abdominal pain—Metformin—polycystic ovary syndrome	0.00251	0.00877	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00249	0.00439	CbGpPWpGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00239	0.00421	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00233	0.0041	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.00231	0.00407	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00229	0.00404	CbGpPWpGaD
Paricalcitol—Asthenia—Metformin—polycystic ovary syndrome	0.00228	0.00796	CcSEcCtD
Paricalcitol—UGT1A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00225	0.00397	CbGpPWpGaD
Paricalcitol—Pruritus—Metformin—polycystic ovary syndrome	0.00225	0.00785	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.00223	0.00393	CbGpPWpGaD
Paricalcitol—Diarrhoea—Metformin—polycystic ovary syndrome	0.00217	0.00759	CcSEcCtD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00217	0.00383	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00217	0.00382	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00216	0.00381	CbGpPWpGaD
Paricalcitol—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00214	0.0165	CbGeAlD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00213	0.00376	CbGpPWpGaD
Paricalcitol—Dizziness—Metformin—polycystic ovary syndrome	0.0021	0.00733	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.0021	0.0037	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00207	0.00365	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.00206	0.00363	CbGpPWpGaD
Paricalcitol—Vomiting—Metformin—polycystic ovary syndrome	0.00202	0.00705	CcSEcCtD
Paricalcitol—Rash—Metformin—polycystic ovary syndrome	0.002	0.00699	CcSEcCtD
Paricalcitol—Dermatitis—Metformin—polycystic ovary syndrome	0.002	0.00699	CcSEcCtD
Paricalcitol—Headache—Metformin—polycystic ovary syndrome	0.00199	0.00695	CcSEcCtD
Paricalcitol—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00198	0.0035	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00197	0.00347	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00197	0.00347	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.00196	0.00346	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00194	0.00341	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—CCNB1—polycystic ovary syndrome	0.0019	0.00336	CbGpPWpGaD
Paricalcitol—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.0019	0.00334	CbGpPWpGaD
Paricalcitol—Nausea—Metformin—polycystic ovary syndrome	0.00189	0.00659	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00186	0.00328	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00183	0.00323	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00183	0.00323	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00173	0.00305	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00173	0.00305	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ZNF430—polycystic ovary syndrome	0.00172	0.00304	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ZNF205—polycystic ovary syndrome	0.00172	0.00304	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00171	0.00302	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.0017	0.00301	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00169	0.00298	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.00166	0.00292	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00165	0.00291	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00156	0.00276	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00149	0.00263	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ADARB1—polycystic ovary syndrome	0.00147	0.00259	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.00144	0.00253	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—BAX—polycystic ovary syndrome	0.0014	0.00247	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00138	0.00243	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00137	0.00241	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00136	0.0024	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00135	0.00238	CbGpPWpGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00131	0.00231	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—NRG1—polycystic ovary syndrome	0.0013	0.00229	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00127	0.00224	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00121	0.00214	CbGpPWpGaD
Paricalcitol—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.0012	0.00211	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—LSM5—polycystic ovary syndrome	0.0012	0.00211	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00116	0.00204	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00113	0.00199	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SAP30L—polycystic ovary syndrome	0.00111	0.00196	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SUOX—polycystic ovary syndrome	0.00111	0.00196	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00111	0.00196	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.0011	0.00194	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.0011	0.00193	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00109	0.00192	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00109	0.00192	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00103	0.00182	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—POMC—polycystic ovary syndrome	0.00103	0.00181	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00101	0.00178	CbGpPWpGaD
Paricalcitol—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.001	0.00176	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.00097	0.00171	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000962	0.0017	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—TEAD2—polycystic ovary syndrome	0.000945	0.00167	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000941	0.00166	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000938	0.00165	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—SERPINE1—polycystic ovary syndrome	0.000928	0.00164	CbGpPWpGaD
Paricalcitol—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000925	0.00163	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000893	0.00157	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000887	0.00156	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SUOX—polycystic ovary syndrome	0.000887	0.00156	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TEAD2—polycystic ovary syndrome	0.000877	0.00155	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000877	0.00155	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—BCL2—polycystic ovary syndrome	0.000853	0.0015	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000843	0.00149	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00083	0.00146	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000824	0.00145	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000822	0.00145	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000819	0.00144	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000735	0.0013	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000701	0.00124	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000701	0.00124	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000701	0.00124	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000697	0.00123	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000692	0.00122	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RPL37A—polycystic ovary syndrome	0.000673	0.00119	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—STAR—polycystic ovary syndrome	0.000665	0.00117	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000657	0.00116	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000656	0.00116	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000651	0.00115	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000643	0.00113	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000638	0.00112	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000637	0.00112	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMMR—polycystic ovary syndrome	0.000592	0.00104	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000587	0.00104	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000568	0.001	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000565	0.000997	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000559	0.000985	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000557	0.000982	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000557	0.000982	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—STAR—polycystic ovary syndrome	0.000531	0.000937	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00053	0.000934	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000528	0.000931	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000516	0.000909	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LHB—polycystic ovary syndrome	0.000515	0.000909	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000515	0.000909	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000514	0.000906	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000509	0.000897	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000504	0.000888	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000495	0.000873	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000488	0.00086	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMMR—polycystic ovary syndrome	0.000474	0.000835	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000452	0.000797	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—YAP1—polycystic ovary syndrome	0.000452	0.000796	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000449	0.000792	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—RRM2—polycystic ovary syndrome	0.000435	0.000767	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—YAP1—polycystic ovary syndrome	0.000419	0.000739	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000418	0.000737	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000416	0.000733	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LHB—polycystic ovary syndrome	0.000412	0.000726	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00041	0.000723	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NAMPT—polycystic ovary syndrome	0.000403	0.00071	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000403	0.00071	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.0004	0.000706	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000399	0.000704	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000398	0.000703	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000398	0.000701	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000395	0.000696	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PGR—polycystic ovary syndrome	0.000394	0.000695	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.00039	0.000688	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000376	0.000662	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP17A1—polycystic ovary syndrome	0.00037	0.000652	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000365	0.000644	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.00036	0.000634	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000359	0.000633	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—RRM2—polycystic ovary syndrome	0.000348	0.000613	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000341	0.000601	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000337	0.000594	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000336	0.000592	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—YAP1—polycystic ovary syndrome	0.000335	0.000591	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000322	0.000568	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TH—polycystic ovary syndrome	0.00032	0.000564	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000318	0.000561	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000311	0.000549	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00031	0.000546	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AR—polycystic ovary syndrome	0.000307	0.000541	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000302	0.000532	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.0003	0.000529	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000298	0.000525	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000296	0.000521	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000293	0.000516	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000281	0.000496	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000281	0.000495	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000277	0.000488	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NCOR1—polycystic ovary syndrome	0.000268	0.000473	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GNAS—polycystic ovary syndrome	0.000261	0.00046	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TH—polycystic ovary syndrome	0.000256	0.000451	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000251	0.000443	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NCOR1—polycystic ovary syndrome	0.000249	0.000439	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000249	0.000439	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR3C1—polycystic ovary syndrome	0.000248	0.000437	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000236	0.000416	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000234	0.000412	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000222	0.000391	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTHFR—polycystic ovary syndrome	0.00022	0.000388	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000219	0.000386	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GNAS—polycystic ovary syndrome	0.000209	0.000368	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NCOR1—polycystic ovary syndrome	0.000199	0.000351	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARG—polycystic ovary syndrome	0.000192	0.000339	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000189	0.000332	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000179	0.000316	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARG—polycystic ovary syndrome	0.000178	0.000314	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000176	0.000311	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—POMC—polycystic ovary syndrome	0.000176	0.00031	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTHFR—polycystic ovary syndrome	0.000176	0.00031	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—INS—polycystic ovary syndrome	0.000175	0.000308	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000173	0.000305	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000157	0.000278	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000144	0.000254	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000144	0.000254	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARG—polycystic ovary syndrome	0.000143	0.000251	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—POMC—polycystic ovary syndrome	0.000141	0.000248	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—INS—polycystic ovary syndrome	0.00014	0.000246	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000134	0.000236	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000133	0.000235	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000114	0.000201	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000114	0.000201	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.54e-05	0.000168	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.04e-05	0.000159	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.62e-05	0.000152	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.69e-05	0.000136	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.33e-05	0.000129	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.69e-05	0.000118	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.54e-05	0.000115	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.33e-05	0.000112	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.83e-05	0.000103	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.64e-05	9.95e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.44e-05	9.59e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.23e-05	9.21e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.16e-05	9.1e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.87e-05	8.59e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.8e-05	8.46e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.15e-05	7.32e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.04e-05	7.12e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.8e-05	6.7e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.39e-05	5.98e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.23e-05	5.69e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.06e-05	5.4e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.85e-05	5.03e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.31e-05	4.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.28e-05	4.02e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.27e-05	4e-05	CbGpPWpGaD
